The Treatment of Contour Scars: Filling Agents
Gary
D. Monheit, M.D.
Associate Professor
Department of Dermatology
University of Alabama at Birmingham
Birmingham, Alabama
Over the past thirty years, the methods available for the removal or
improvement of acne and contour scars on the
face increased exponentially with the advent of new skin filler substances,
improved techniques for elevating existing scars and technology for
abrading and resurfacing facial contours. It seems that every month,
a new and improved filling agent or laser
is available that will be the best of all available methods. In the
midst of these technological breakthroughs, the basic mechanisms still
remain the same. There are three categories of techniques presently
available to improve acne scars: 1) scar removal and revision; 2) filling
depressed scars; 3) contouring the surface of scars.
Thirty
years ago, one would either excise a scar or dermabrade the surface.
Combinations of these two methods were beginning along with punch grafts
and the use of autodermal grafts. The basic work-up and evaluation of
these scars essentially remains the same because these same choices
are available for types of scars the clinician will evaluate for improvement.
This review will discuss skin filling agents available for scar correction.
Distensible
cutaneous scars are best elevated with filling material. A distensible
scar is defined as one which will rise to the surface when tension is
placed on either side. This simple test will tell the clinician if scars
respond to filling material. Those fibrotic ice pick and bound down
scars cannot be elevated because the scar tissue extends through to
the subcutaneous tissue plane. Placing filling material in the dermis
will only elevate the surrounding skin, producing a donut effect and
making the scar appear worse.
The ideal
skin filling agent is safe, physiologic, simple and permanent. At this
point, there is no known substance that meets all these criteria. Each
of the available substances have side effects that detract from these
properties but all of them strived to perfect their qualities to fulfill
these requirements. The list of injectable filling materials increases
each month with both synthetic and natural substances. Other implant
materials are surgically placed. The excisional procedures place the
synthetic implant materials within or below the scar for elevation.
A current list of implant material available for acne scars is listed
in Table I.
Injectable Filling Material
1)Zyderm and Zyplast Collagen
The first injectable filling material to be approved by the FDA is Zyderm
collagen. This porcine collagen implant has been used for approximately
ten years and the injection technique has been standardized. Each is
delivered in 1 cc. syringes packaged with lidocaine and a 30 gauge needle.
There are three variations available for this collagen implant. Zyderm
I collagen is a 25% suspension of purified porcine dermis in saline
with a 0.3% lidocaine. The saline carrier is absorbed and the remaining
implant persists for six to ten months. Zyderm I is used most successfully
to treat shallow distensible scars and fine scars. Zyderm II has double
the concentration and is a more viscid substance. The longevity of scar
correction is increased and it can be used for larger filling defects.
Zyplast is a cross-linked derivative of porcine collagen which is a
heavier filling material and has greater longevity. Zyplast can be used
for larger scars that require a greater and deeper filling of volume
and will last longer. It is placed deeper in the dermis and gives 100%
correction at the time of implantation rather than 150% used for Zyderm
I. Zyderm I has a longevity of six weeks to three months; Zyderm II,
four to five months, while Zyplast may last nine months to one year,
especially in a relatively immobile scar.
These two
filling agents are the most commonly used in implants in the United
States today with a low abuse potential. They are user friendly, relatively
easy to inject, and can be integrated into a simple office visit for
the patient requesting dermal augmentation. Frequent maintenance, though,
is necessary and the question always arises whether it is cost-effective.
The filling agent is technique dependent for longer lasting results,
proportional to the clinician’s ability to place the collagen
correctly. Adverse reactions have been noted including allergic reactions,
hypersensitivity reactions with Zyderm I and II and vascular necrosis
occurring with Zyplast, particularly in the glabella and on the nose.
Though these complications are rare, they have been reported and proper
allergy testing must be done for each patient.
2) Fibrel
Fibrel has been an effective method of elevating scars utilizing three
agents – gelatin, amino caproic acid and plasma that are injected
within or under a scar to stimulate collagenosis. This has subsequently
been refined and simplified so that the plasma is not a necessary component
in the mixture. This “new Fibrel” is composed of a gelatin
powder, amino caproic acid mixed with saline and 1% lidocaine. The mixture
is placed within distensible scars and gives correction for over one
year. In selective cases, scar elevation has persisted for up to five
years. Side effects have included a prolonged inflammatory reaction
in selective cases, probably related to an idiosyncratic sensitivity
response to the products. It has been used extensively in Zyderm allergic
patients and has been a reliable filling agent for acne scars. Recent
problems with production and availability presently make this product
hard to find for clinical use.
3) Artecoll
Artecoll is a synthetic mixture of polymethyl methacrolate microspheres
(PMMA) suspended in collagen, saline and 0.3% lidocaine. The mixture
is injected deeply in the dermis and subcutaneous tissue and following
injection, the collagen is gradually degraded with the permanent deposition
of the PMMA spheres. Artecoll should be injected subdermally and overcorrection
avoided with no blanching of the dermis. Broad experience in Europe
has found this product reliable and long-lasting and its use in acne
scars is well documented. It presently is not available in the United
States but soon to be approved by the FDA for widespread usage.
4) Hylaform
Gel
Hylaform Gel is a hylauronic acid derivative of a mammalian polysaccharide.
It is a cross-linked derivative of natural hylauronan polymer with little
immunologic activity and no species specificity. It is an intradermal
injection used to augment scars. No skin test is required but the procedure
requires a series of injections rather than a single treatment session.
After two or three injections, the initial clinical trials have resulted
in 80% of patients satisfied with their correction at twelve weeks.
Longevity, though, is nine months to one year and reinjection then is
necessary. Adverse reactions have been minimal including erythema, ecchymosis
and acneiform dermatitis with no reported allergic reactions. This product
is available in Europe and under investigation in the United States.
5) Resoplast
Resoplast is a monomolecular bovine collage product suspended in solution
at 3.5 and 6.5% concentration. It is very similar to Zyderm I and II
and its indications and techniques of implantation are the same. A skin
test is necessary with similar risks of allergenicity. If one is allergic
to Zyderm collagen, it also applies to Resoplast as the products have
similar antigenicity.
6) Autologen
Autologen is an injectable dermal implant harvested from autologous
collagen. It provides two theoretical advantages on an implant material:
1) It is autologous: allergic and tissue reactions should not occur;
2) It contains intact dermal collagen fibers which may exhibit greater
resistance to enzymatic degradation.
The skin material is provided from skin specimens obtained from plastic
and reconstructive surgery procedures in which skin is removed and discarded.
The removed skin is processed into collagen dispension concentrations
from 25 mg/ml to 100 mg/ml and injected through a 27 gauge to 30 gauge
syringe.
Results
from controlled evaluations in thirty patients show that three layered
Autologen treatments provided greater than 75% correction for more than
one year.
7) Isolagen
Isolagen is also a method of harvesting autologous collagen, purifying
the material and packaging it in a suspension for intradermal injection.
Results are promising but objective data is presently not available.
Methods
include harvesting the skin from patients prior to the procedure which
they are sent to home laboratory for processing. From this model, autologous
collagen is produced, repackaged and sent back to the clinician. Because
the product is autologous, there is little risk of allergic response
and the collagen functions as an autoimplant. Once harvested and processed,
a long term supply of collagen is then available for the patient as
secondary procedures are required to maintain scar correction. These
are currently under investigation and may soon be available for selected
patients.
8) Fat
Fat injections have been available and performed over one-hundred years
as live, free fat grafts. Liposuction has made the harvesting of fat
a simpler procedure and for grafting, this is done with a syringe in
an atraumatic manner. The best donor sites include the thighs, buttocks,
knees and abdomen and the resultant fat is then gently centrifuged to
separate the intact fat cells from supernatant serum free lipid. Fat
cells are then injected into a subcutaneous plane under larger scars
with a 16 to 18 gauge needle. Fat is used as a subcutaneous filling
substance and is not indicated in dermal augmentation. Thus, it is reserved
for those large, atrophic defects that include skin and fat. Larger
acne scars and lipodystrophies are best for fat correction. Recent techniques
have resulted in fat survival for over one year and 50% or greater of
patients treated. These results are technique sensitive requiring many
different methods to purify, wash, separate, centrifuge or prepare the
fat. Each investigator seems to have a different method to justify results.
Unified techniques are needed to standardize the technique.
Surgical
Methods
Other procedures include surgical methods of replacing or implanting
material into dermis for scar elevation. 1) Dermal grafting is not a
new technique but recently has been perfected by Swinehart. Dermis is
surgically harvested and de-epithelialized. According to Swinehart’s
method, the area for surgical excision is first dermabraded to remove
the epidermis. An excision of collagen is then performed and the defect
closed. A prime location is the retroauricular sulcus and neck. The
dermis is defatted, placed in saline, and then divided into sections
to fit the size defect needed. A simple stab incision is made to create
a pocket within and under the scar in which the dermal implants are
placed. Because this represents a graft rather than just substance,
there is little absorption and the results appear to be long term. It
is truly a skin transplant of both cellular fibroblasts and collagen
that maintain long-term correction. It is, though, a surgical procedure
more complex than a simple injection and is quite technique sensitive.
2) Similarly,
synthetic grafts such as Gore-Tex and SoftForm can be used to fill scars
also. These are synthetic products that are placed surgically within
and under the dermis for augmentation. Gore-Tex is a polytetrafluorethylene
product that has been used extensively in cardiovascular, urologic and
reconstructive surgery. Its placement for skin augmentation must be
done in the superficial subcutaneous tissue below the skin and anchored
in a subdermal pocket. It is a technique sensitive operation with adverse
reactions that include infection, foreign body extrusion, and movement
of the implant from the site of placement. The product is best for atrophic
scars and full thickness skin defects and subcutaneous defects and requires
significant augmentation. The implant, though, is permanent and movement
or extrusion needs replacement and will require surgical revision.
The use
of either injectable or surgically placed implants for the correction
of acne scars is dependent upon the surgeon and the patient’s
desires. Many patients are satisfied with the simple but repeatable
procedure of Zyderm collagen while others insist upon a single procedure.
Both of these choices are available with the advent of new injectable
and implantable skin filling substances.